HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Parsing metabolic heterogeneity in mood disorders: A hypothesis-driven cluster analysis of glucose and insulin abnormalities.

AbstractOBJECTIVES:
Metabolically based distinctions for disturbances in glucose and insulin may provide meaningful insights both clinically and mechanistically.
METHODS:
Data were derived from 352 subjects of previously completed clinical studies with a mood disorder (MD) (bipolar disorder: n = 179, major depressive disorder: n = 173) and 218 healthy controls from the Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy. We conducted a factor analysis to replicate a priori dissociable factors informed by glucose and insulin levels and indices of insulin resistance and beta-cell function: elevated insulin and insulin resistance ("insulin-IR"), and increased fasting glucose and reduced insulin secretion ("glucotoxicity"). Cluster analyses were conducted, separately in men and women, to evaluate the clinical relevance of subtyping individuals with MDs using insulin-IR and glucotoxicity (GT) factor scores.
RESULTS:
Factors insulin-IR and GT explained 92.64% and 92.09% of the variance in men and women respectively. Three clusters were replicated in men and women separately: metabolically healthy (MH), high GT, and insulin-resistant (IR). After adjusting for age, gender, study cohort, MD diagnosis, and antipsychotics use, body mass index (BMI) and mean arterial pressure were higher in IR- vs GT- or MH-clustered individuals; GT-clustered individuals had more metabolic syndrome components and higher C-reactive protein. Glucotoxic-clustered subjects reported greater impairments in cognitive function and global functioning when compared to MH- or IR-clustered subjects.
CONCLUSIONS:
Using simple, cost-effective, and accessible measures, we identified stable, gender-convergent, subgroups of individuals that significantly diverged on measures of cognitive dysfunction, self-reported anhedonia, functional disability, BMI, and blood pressure.
AuthorsRodrigo B Mansur, Yena Lee, Mehala Subramaniapillai, Danielle S Cha, Elisa Brietzke, Roger S McIntyre
JournalBipolar disorders (Bipolar Disord) Vol. 22 Issue 1 Pg. 79-88 (02 2020) ISSN: 1399-5618 [Electronic] Denmark
PMID31464359 (Publication Type: Journal Article)
Copyright© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Chemical References
  • Blood Glucose
  • Insulin
  • C-Reactive Protein
Topics
  • Adult
  • Anhedonia
  • Bipolar Disorder (blood, diagnosis)
  • Blood Glucose (metabolism)
  • C-Reactive Protein (analysis)
  • Cluster Analysis
  • Cognitive Dysfunction (diagnosis)
  • Depressive Disorder, Major (blood, diagnosis)
  • Female
  • Humans
  • Insulin (blood)
  • Insulin Resistance
  • Male
  • Metabolic Syndrome (diagnosis, psychology)
  • Middle Aged
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: